PTCT Butterfly Strategy
PTCT (PTC Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
PTC Therapeutics, Inc. (PTCT) is a biopharmaceutical company committed to the research, development, and commercialization of innovative therapies for patients afflicted with rare genetic disorders. Its robust pipeline encompasses both commercialized therapies and a variety of experimental drug candidates, spanning all stages of development—from early research and preclinical studies to clinical trials—with a primary focus on addressing various rare disease indications. Among its commercialized products, PTC Therapeutics provides Translarna and Emflaza, offering therapeutic options for Duchenne muscular dystrophy patients in the European Economic Area and the United States. Translarna also addresses nonsense mutation Duchenne muscular dystrophy in Brazil and Russia. The company additionally commercializes Tegsedi and Waylivra for various rare conditions throughout Latin America and the Caribbean. Furthermore, in Brazil, PTC Therapeutics distributes Evrysdi as a treatment for spinal muscular atrophy (SMA) in patients aged two months and older.
PTCT (PTC Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $6.06B, a beta of 0.55 versus the broader market, a 52-week range of 45.425-90.87, average daily share volume of 1.6M, a public-listing history dating back to 2013, approximately 991 full-time employees. These structural characteristics shape how PTCT stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.55 indicates PTCT has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a butterfly on PTCT?
A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration.
PTCT snapshot
As of August 14, 2026, spot at $71.93, ATM IV 49.70%, IV rank 16.44%, expected move 14.25%. The butterfly on PTCT below is built from the August 14, 2026 end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 35-day expiry.
Why this butterfly structure on PTCT specifically: PTCT IV at 49.70% is on the cheap side of its 1-year range, which favors premium-buying structures like a PTCT butterfly, with a market-implied 1-standard-deviation move of approximately 14.25% (roughly $10.25 on the underlying). The 35-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PTCT expiries trade a higher absolute premium for lower per-day decay. Position sizing on PTCT should anchor to the underlying notional of $71.93 per share and to the trader's directional view on PTCT stock.
PTCT butterfly setup
The PTCT butterfly below is built from the August 14, 2026 end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PTCT at $71.93 on that close, the first option leg uses a $70.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PTCT chain at a 35-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PTCT shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $70.00 | $5.10 |
| Sell 2 | Call | $70.00 | $5.10 |
| Buy 1 | Call | $75.00 | $3.40 |
PTCT butterfly risk and reward
- Net Premium / Debit
- +$170.00
- Max Profit (per contract)
- $170.00
- Max Loss (per contract)
- -$330.00
- Breakeven(s)
- $71.70
- Risk / Reward Ratio
- 0.515
Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit.
PTCT butterfly payoff curve
Modeled P&L at expiration across a range of underlying prices for the butterfly on PTCT. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$170.00 |
| $15.91 | -77.9% | +$170.00 |
| $31.82 | -55.8% | +$170.00 |
| $47.72 | -33.7% | +$170.00 |
| $63.62 | -11.6% | +$170.00 |
| $79.53 | +10.6% | -$330.00 |
| $95.43 | +32.7% | -$330.00 |
| $111.33 | +54.8% | -$330.00 |
| $127.23 | +76.9% | -$330.00 |
| $143.14 | +99.0% | -$330.00 |
When traders use butterfly on PTCT
Butterflies on PTCT are pinning bets - traders use them when they expect PTCT to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
PTCT thesis for this butterfly
The market-implied 1-standard-deviation range for PTCT extends from approximately $61.68 on the downside to $82.18 on the upside. A PTCT long call butterfly is a pinning play: it pays maximum at the middle strike if PTCT settles there at expiration, with the wing legs capping both the cost and the maximum loss to the net debit. Current PTCT IV rank near 16.44% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on PTCT at 49.70%. As a Healthcare name, PTCT options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PTCT-specific events.
PTCT butterfly positions are structurally neutral / pin (limited-risk, limited-reward); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PTCT positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PTCT alongside the broader basket even when PTCT-specific fundamentals are unchanged. Always rebuild the position from current PTCT chain quotes before placing a trade.
Frequently asked questions
- What is a butterfly on PTCT?
- A butterfly on PTCT is the butterfly strategy applied to PTCT (stock). The strategy is structurally neutral / pin (limited-risk, limited-reward): A long call butterfly buys one lower-strike call, sells two ATM calls, and buys one higher-strike call, paying a small net debit for a defined-risk position that maxes out if the underlying pins the middle strike at expiration. With PTCT stock at $71.93 on the August 14, 2026 close, the strikes shown on this page are snapped to the nearest listed PTCT chain strike and the premiums come straight from that session's bid/ask midpoint.
- How are PTCT butterfly max profit and max loss calculated?
- Max profit equals the wing width minus net debit times 100 (reached when the underlying pins the middle strike); max loss equals the net debit times 100. Two breakevens at lower-wing plus debit and upper-wing minus debit. For the PTCT butterfly priced from the August 14, 2026 end-of-day chain at a 30-day expiry (ATM IV 49.70%), the computed maximum profit is $170.00 per contract and the computed maximum loss is -$330.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PTCT butterfly?
- The breakeven for the PTCT butterfly priced on this page is roughly $71.70 at expiration, derived from the August 14, 2026 end-of-day chain's premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The PTCT market-implied 1-standard-deviation expected move in the same options snapshot is approximately 14.25%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a butterfly on PTCT?
- Butterflies on PTCT are pinning bets - traders use them when they expect PTCT to settle near a specific level at expiration (often the prior close, a round number, or the max-pain strike) and want defined-risk exposure to that outcome.
- How does current PTCT implied volatility affect this butterfly?
- PTCT ATM IV is at 49.70% with IV rank near 16.44%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.